Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3MANGIA, Alessandra; SANTORO, Rosanna; ROMANO, Mario et al.The New England journal of medicine. 2005, Vol 352, Num 25, pp 2609-2617, issn 0028-4793, 9 p.Article

High doses of interferon in combination with ribavirin are more effective than the standard regimen in patients with HCV genotype 1 chronic hepatitisMANGIA, Alessandra; SANTORO, Rosanna; CELA, Marina et al.Journal of hepatology. 2002, Vol 37, Num 1, pp 109-116, issn 0168-8278Article

Individualized Treatment Duration for Hepatitis C Genotype 1 Patients: A Randomized Controlled TrialMANGIA, Alessandra; MINERVA, Nicola; CRISTOFARO, Giuseppe et al.Hepatology (Baltimore, Md.). 2008, Vol 47, Num 1, pp 43-50, issn 0270-9139, 8 p.Article

Incidence rates of post-ERCP complications : A systematic survey of prospective studiesANDRIULLI, Angelo; LOPERFIDO, Silvano; NAPOLITANO, Grazia et al.The American journal of gastroenterology. 2007, Vol 102, Num 8, pp 1781-1788, issn 0002-9270, 8 p.Article